Cargando…
Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study
BACKGROUND: The study evaluated efficacy and safety of the 2 mg dose of prucalopride compared to placebo in patients with chronic constipation (CC) from the Asia-Pacific region. METHODS: Randomized, placebo-controlled, parallel-group, phase III study with 2-week run-in, 12-week treatment phase, and...
Autores principales: | Ke, M, Zou, D, Yuan, Y, Li, Y, Lin, L, Hao, J, Hou, X, Kim, HJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509366/ https://www.ncbi.nlm.nih.gov/pubmed/22882724 http://dx.doi.org/10.1111/j.1365-2982.2012.01983.x |
Ejemplares similares
-
Response to letter: Balancing risks and benefits of prucalopride for the treatment of chronic constipation in Asians
por: Ke, M, et al.
Publicado: (2013) -
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic Constipation
por: Yiannakou, Yan, et al.
Publicado: (2015) -
Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation
por: Cuffari, Carmen, et al.
Publicado: (2023) -
Effect of prucalopride on symptoms of chronic constipation
por: Tack, J, et al.
Publicado: (2013) -
Factors Predictive of Treatment-Emergent Adverse Events of Prucalopride: An Integrated Analysis of Four Randomized, Double-Blind, Placebo-Controlled Trials
por: Leelakusolvong, Somchai, et al.
Publicado: (2015)